NEW YORK (GenomeWeb News) — Bruker Biosciences’ third-quarter revenue increased 22 percent as income jumped by a third, the company said today.
Receipts for the three months ended Sept. 30 rose to $104.8 million from $85.9 million year over year. Product revenues were up 22 percent to $50.1 million and receipts from the company’s services business tallied $8 million, a third more than the same period last year.
The company attributed much of the revenue growth to its acquisition of Bruker Optics for $135 million in July.
Bruker said it will continue to look for ways to improve organic earnings in its core business.
Spending on research and development remained flat at $12 million.
Bruker said profits in the period increased by a third to $3 million.
The company said it had around $44.1 million in cash and short term investments as of Sept. 30.